Literature DB >> 8807259

Expression of estrogen and progesterone receptors in cytologic specimens using various fixatives.

J A Hudock1, C A Hanau, R Christen, M Bibbo.   

Abstract

Estrogen and progesterone receptor reactivity may be useful in identifying possible primary sites of metastatic disease or directing therapy in tumors of the female genital tract, including breast, ovary, and endometrium. Various methods have been described for the immunocytochemical evaluation of estrogen receptor (ER) and progesterone receptor (PR) status of cytologic specimens but our results have been variable. We evaluated the effectiveness of various fixatives [cytospin collection fluid, Shandon, Pittsburgh, PA (SH); ethanol (ETH); and formalin (FOR)] for fixation of smears (SM) and cell block (CB) material. The percentage and intensity of tumor nuclei of SM, CB, and tissue sections (TS) stained for ER and PR by the avidin-biotin-peroxidase complex technique were compared. Samples were considered ER or PR positive when > or = 20% of tumor nuclei were stained. The sensitivity of ER analysis of SMs and CBs in each fixative compared to formalin-fixed paraffin-embedded tissue sections were as follows: SM (SH) 88%, SM (ETH) 14%, CB (SH) 58%, CB (ETH) 43%, and CB (FOR) 70%. The sensitivity of PR determination on SMs and CBs was SM (SH) 71%, SM (ETH) 6.0%, CB (SH) 25%, CB (ETH) 33%, CB (FOR) 80%. These findings indicate that of the fixatives evaluated for ER analysis, SMs fixed in SH provided the best results. For PR evaluation, CBs fixed in FOR gave the best results.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8807259     DOI: 10.1002/(SICI)1097-0339(199607)15:1<78::AID-DC17>3.0.CO;2-9

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  6 in total

1.  Evaluation of non-formalin tissue fixation for molecular profiling studies.

Authors:  John W Gillespie; Carolyn J M Best; Verena E Bichsel; Kristina A Cole; Susan F Greenhut; Stephen M Hewitt; Mamoun Ahram; Yvonne B Gathright; Maria J Merino; Robert L Strausberg; Jonathan I Epstein; Stanley R Hamilton; Gallya Gannot; Galina V Baibakova; Valerie S Calvert; Michael J Flaig; Rodrigo F Chuaqui; Judi C Herring; John Pfeifer; Emmanuel F Petricoin; W Marston Linehan; Paul H Duray; G Steven Bova; Michael R Emmert-Buck
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

2.  Usefulness of liquid-based cytology in hormone receptor analysis of breast cancer specimens.

Authors:  Rieko Nishimura; Kenjiro Aogi; Tamami Yamamoto; Daisuke Takabatake; Seiki Takashima; Norihiro Teramoto; Akihiro Kagawa; Sachiko Morita
Journal:  Virchows Arch       Date:  2010-12-21       Impact factor: 4.064

3.  Determination of HER-2 status on FNAC material from breast carcinomas using in situ hybridization with dual chromogen visualization with silver enhancement (dual SISH).

Authors:  Elsa Beraki; Torill Sauer
Journal:  Cytojournal       Date:  2010-10-11       Impact factor: 2.091

Review 4.  Latest biopsy approach for suspected metastases in patients with breast cancer.

Authors:  Naoki Niikura; Bruno C Odisio; Yutaka Tokuda; Fraser W Symmans; Gabriel N Hortobagyi; Naoto T Ueno
Journal:  Nat Rev Clin Oncol       Date:  2013-10-22       Impact factor: 66.675

5.  Liquid based material from fine needle aspirates from breast carcinomas offers the possibility of long-time storage without significant loss of immunoreactivity of estrogen and progesterone receptors.

Authors:  Torill Sauer; Kristin Ebeltoft; Mette Kristin Pedersen; Rolf Kåresen
Journal:  Cytojournal       Date:  2010-12-31       Impact factor: 2.091

6.  Immunocytochemical expression of Ki-67/p16 in normal, atypical, and neoplastic cells in urine cytology using BD SurePath™ as preparation method.

Authors:  Kirsten Margrethe Østbye; Mette Kristin Pedersen; Torill Sauer
Journal:  Cytojournal       Date:  2019-12-05       Impact factor: 2.091

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.